A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Thomas Jefferson University
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Bristol-Myers Squibb
Polish Lymphoma Research Group
Merck Sharp & Dohme LLC
Astellas Pharma Inc
University of Cologne
Seagen Inc.
University College, London
ADC Therapeutics S.A.
Memorial Sloan Kettering Cancer Center
Jiangsu HengRui Medicine Co., Ltd.
Baylor College of Medicine
City of Hope Medical Center
Stanford University
SCRI Development Innovations, LLC
Bristol-Myers Squibb
Washington University School of Medicine
New York Medical College
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Center for International Blood and Marrow Transplant Research
West Virginia University
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Virginia Commonwealth University
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
CStone Pharmaceuticals